A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China
Trending
- Nikki Giovanni’s Insistent Black Love: A Memory
- ‘A Forgotten Migration’: Dr. Crystal R. Sanders Uncovers The Legacy Of ‘Segregation Scholarships’ In New Book
- 7 Nikki Giovanni Poems That Will Lift Your Spirits
- Eric Garner’s Mother Gwen Carr Suggests Race Factored In Daniel Penny Verdict: ‘2 Justice Systems’
- Stay Scam Free: 10 Tips To Avoid Holiday Scammers
- The Year It All Came Together: The Roots Announce ‘A Roots Picnic Experience: Class of ’95′ Featuring Lil Kim, Method Man, E-40 & More + A Playlist Of The Performer’s Biggest Hits
- Blue Ivy Steals The Spotlight At The ‘Mufasa: The Lion King’ Premiere In Christian Siriano
- 5 things to watch as Syria confronts a new future